Number of items: 4.
2024
Derby, S. et al.
(2024)
Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial.
International Journal of Radiation Oncology, Biology, Physics, 118(5),
pp. 1371-1378.
(doi: 10.1016/j.ijrobp.2024.01.011)
(PMID:38211641)
Derby, S. et al.
(2024)
Concurrent olaparib and radiation therapy in older patients with newly diagnosed glioblastoma: the phase 1 dose-escalation PARADIGM trial.
International Journal of Radiation Oncology, Biology, Physics, 118(5),
pp. 1371-1378.
(doi: 10.1016/j.ijrobp.2024.01.011)
(PMID:38211641)
2022
Jackson, M. R. et al.
(2022)
Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis.
International Journal of Radiation Oncology, Biology, Physics, 112(1),
pp. 197-211.
(doi: 10.1016/j.ijrobp.2021.08.029)
(PMID:34478832)
(PMCID:PMC8406661)
2020
Hanna, C. et al.
(2020)
Pharmacokinetics, safety and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.
Neuro-Oncology, 22(12),
pp. 1840-1850.
(doi: 10.1093/neuonc/noaa104)
(PMID:32347934)
(PMCID:PMC7746945)
This list was generated on Thu Nov 7 12:54:45 2024 GMT.